藥物輸送裝置市場規模、佔有率和成長分析（按給藥途徑、應用、最終用途和地區分類）－2026-2033年產業預測

預計到 2024 年，藥物輸送設備市場規模將達到 2,941.7 億美元，到 2025 年將達到 3,115.2 億美元，到 2033 年將達到 4,927.9 億美元，預測期（2026-2033 年）的複合年成長率為 5.9%。

藥物輸送裝置市場正經歷顯著成長，這主要得益於先進技術的日益融合，這些技術能夠增強標靶藥物傳輸。這些裝置透過確保最佳劑量，最大限度地減少副作用，從而降低所需活性成分的總量，最終降低產品成本。人們對新型藥物輸送解決方案日益成長的興趣，推動了廣泛的研發活動，重點在於提升病患的便利性、可及性和精準度。生物製藥產業的蓬勃發展進一步支撐了這一成長趨勢，該產業正在催生許多新型治療方法。此外，製造商對臨床試驗投入的不斷增加，以及監管機構的積極參與，共同創造了有利於創新藥物研發的良好環境。

全球藥物輸送裝置市場按給藥途徑、應用領域、最終用途和地區進行細分。依給藥途徑分類，可分為口服、吸入、經皮、注射、眼科、鼻腔、局部用藥及其他。依應用領域分類，可分為腫瘤、感染疾病、呼吸系統疾病、糖尿病、心血管疾病、自體免疫疾病、中樞神經系統疾病及其他。依最終用途分類，可分為醫院、診斷中心、門診手術中心/診所、居家醫療機構及其他。依地區分類，可分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

驅動藥物輸送設備市場的因素

藥物輸送設備市場的擴張主要得益於聯邦政府不斷增加的投資，預計將進一步推動市場成長。此外，醫療產業公共和私營部門的進步，尤其是在發展中地區，有望釋放巨大的市場機會。政府旨在為服務不足地區提供感染疾病、呼吸系統疾病、糖尿病和心血管疾病等疾病有效治療的舉措，進一步增強了市場發展的潛力。資金籌措、醫療保健水準的提高以及針對性措施的結合，將成為推動市場向前發展的動力。

藥物輸送裝置市場的限制因素

藥物輸送裝置市場面臨來自多種替代系統的挑戰，包括口服藥物、靜脈注射和經皮吸收貼片，這些系統正在爭取使用者青睞。特定給藥方式的選擇受多種因素影響，包括具體的醫療需求、病患的個人偏好、藥物本身的特性。由於醫護人員和患者會根據自身情況和需求權衡每種方法的利弊，這些相互競爭的給藥方式可能會限制皮下給藥裝置的成長和普及。因此，市場正面臨這些替代解決方案的阻力。

藥物輸送裝置市場趨勢

藥物輸送裝置市場呈現強勁成長勢頭，這主要得益於皮下給藥方式的日益普及以及人們對生物相似藥和生物製藥的關注度不斷提高。隨著醫療機構尋求針對複雜疾病更精準、更具標靶性的治療方法，皮下給藥系統因其便捷高效而日益受到重視。這種轉變不僅透過易用性提高了患者的依從性，也有助於增強生物製藥和生物相似藥的療效。因此，製造商正致力於創新設計和先進技術以滿足這一需求，並將皮下給藥定位為不斷發展的藥物傳輸領域中的關鍵要素。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析及其影響

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 價值鏈分析
• 案例研究分析
• PESTEL 分析
• 市場吸引力指數
• 定價分析

全球藥物輸送裝置市場規模（依給藥途徑及複合年成長率分類）（2026-2033 年）

• 口服
• 吸入
• 經皮
• 注射
• 眼科
• 鼻腔
• 外用
• 其他

全球藥物傳輸設備市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 腫瘤學
• 感染疾病
• 呼吸系統疾病
• 糖尿病
• 循環系統疾病
• 自體免疫疾病
• 中樞神經系統疾病
• 其他

全球藥物傳輸設備市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 醫院
• 診斷中心
• 門診手術中心/診所
• 居家醫療環境
• 其他

全球藥物傳輸設備市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Pfizer, Inc.
• Novartis AG
• BD
• Bayer AG
• UniQure NV
• Sibiono GeneTech Co. Ltd.
• West Pharmaceutical Services Inc.
• Merck
• Teva Pharmaceutical Industries Ltd
• GlaxoSmithKline PLC
• Holozymes Inc.
• Altaris
• Elcam Medical
• Fresenius Medical Care
• Philips Healthcare
• Novo Nordisk
• Teva Pharmaceutical
• Eli Lilly and Company
• CSL Behring
• Amgen Inc.

結論與建議

Drug Delivery Devices Market size was valued at USD 294.17 Billion in 2024 and is poised to grow from USD 311.52 Billion in 2025 to USD 492.79 Billion by 2033, growing at a CAGR of 5.9% during the forecast period (2026-2033).

The market for drug delivery devices is witnessing a significant surge, fueled by the increasing integration of advanced technologies that enhance targeted drug delivery. These devices are instrumental in minimizing side effects by ensuring optimized dosing, leading to a reduction in the overall required quantity of active ingredients and, consequently, lowering product costs. The rising interest in novel drug delivery solutions is spurring extensive research and development efforts, focusing on innovations that improve patient-friendliness, accessibility, and precision. This upward trend is further supported by the expansive growth of the biopharmaceutical sector, which is generating numerous new therapeutic treatments. Additionally, heightened investments from manufacturers in clinical trials, along with proactive regulatory involvement, is fostering a robust landscape for the advancement of innovative pharmaceuticals.

Top-down and bottom-up approaches were used to estimate and validate the size of the Drug Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Drug Delivery Devices Market Segments Analysis

Global Drug Delivery Devices Market is segmented into Route of Administration, Application, End-use, and region. By Route of Administration, the market is classified into Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical, Others. Depending on the Application, it is categorized into Oncology, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others. According to End-use, the market is divided into Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Drug Delivery Devices Market

The expansion of the Drug Delivery Devices market is significantly influenced by rising investment from the federal government, which is likely to accelerate growth. Additionally, both public and private sector advancements within the healthcare industry, particularly in developing regions, are expected to open up substantial market opportunities. Government initiatives aimed at delivering effective treatments for conditions such as cancer, infectious diseases, respiratory issues, diabetes, and cardiovascular diseases to underserved areas further enhance the potential for market development. This combination of funding, healthcare improvements, and targeted initiatives is poised to propel the market forward.

Restraints in the Drug Delivery Devices Market

The Drug Delivery Devices market faces challenges from various alternative systems, such as oral medications, intravenous injections, and transdermal patches, which vie for user preference. The selection of a particular drug administration method is influenced by numerous factors, including the specific medical requirements, individual patient preferences, and the characteristics of the medications themselves. These competing delivery options can limit the growth and adoption of subcutaneous drug delivery devices, as healthcare providers and patients weigh the benefits of each method against their unique circumstances and needs. As a result, the market encounters resistance in favor of these alternative solutions.

Market Trends of the Drug Delivery Devices Market

The Drug Delivery Devices market is witnessing a robust trend driven by the growing emphasis on biosimilars and biologics, with an increasing preference for subcutaneous administration methods. As healthcare providers seek more precise and targeted therapies for complex conditions, subcutaneous drug delivery systems have gained prominence due to their practicality and efficiency. This shift not only enhances patient compliance through ease of use but also supports the therapeutic effectiveness of biologics and biosimilars. Consequently, manufacturers are focusing on innovative designs and advanced technologies to cater to this demand, positioning subcutaneous delivery as a vital component in the evolving landscape of drug administration.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Market Attractiveness Index
• Pricing Analysis

Global Drug Delivery Devices Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Inhalation
• Transdermal
• Injectable
• Ocular
• Nasal
• Topical
• Others

Global Drug Delivery Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology
• Infectious Diseases
• Respiratory Diseases
• Diabetes
• Cardiovascular Diseases
• Autoimmune Diseases
• Central Nervous System Disorders
• Others

Global Drug Delivery Devices Market Size by End-use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers/Clinics
• Home Care Settings
• Others

Global Drug Delivery Devices Market Size & CAGR (2026-2033)

• North America, (Route of Administration, Application, End-use)
  • US
  • Canada
• Europe, (Route of Administration, Application, End-use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Route of Administration, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Route of Administration, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Route of Administration, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Pfizer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UniQure N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sibiono GeneTech Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Holozymes Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altaris
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elcam Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Behring
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation